Sichuan Xinyisheng Pharmaceutical

Sichuan Xinyisheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, focused on the integrated R&D, manufacturing, and marketing of chemical drugs and natural medicine extracts. The company is a significant player in the cardiovascular and cerebrovascular therapeutic segments, notably producing Shuxuening Injection, a widely used Ginkgo biloba extract. With multiple GMP-certified facilities, Xinyisheng produces a diverse range of dosage forms, including injections, tablets, and capsules, catering primarily to the Chinese domestic healthcare market. Its business model emphasizes the modernization of traditional medicine alongside the production of essential chemical generics. The company was established in 2003 and has since expanded its manufacturing capabilities to include large-scale extraction and aseptic processing.